Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Disclosures
保存版の掲載情報です。最新の営業状況・料金・利用条件は出典をご確認ください。
保存されている情報
The Patent and Trademark Office (PTO) is amending the rules for submitting nucleotide or amino acid sequences in computer readable form (CRF) for patent applications. These amendments simplify the requirements of the rules, rearrange portions of the rules for better understanding and establish consistent rules to permit a single internationally acceptable computer readable form. Sequence Listings will be presented in an international, language neutral format using numeric identifiers rather than the current subject headings. The Paper Sequence Listing will preferably be a separately numbered section of the patent application. Sequences which contain fewer than four specifically identified nucleotides or amino acids will no longer be required to be submitted in computer readable form.
- Current entry point
- www.federalregister.gov/documents/1998/06/01/98-14194/requirements-for-patent-applications-containing-nucleotide-sequence-andor-amino-acid-disclosures (permanent link in the Federal Register, verified 2026-09-30)
- Legacy system and where it moved
- No legacy system name mention in title or summary )
- Fee
- No fee mention in title or summary )
- What you need (account or API key)
- No account or key mention in title or summary )
- Published
- 1998-06-01
- Document type
- Rule
原データ更新日：2026-10-06
保存版に記録された日付です。今回の実装・デプロイ日ではありません。